Tag Archives: ALXN

Analysts Offer Insights on Healthcare Companies: Alexion Pharmaceuticals (NASDAQ: ALXN), Quest Diagnostics Inc (NYSE: DGX) and Icon plc (NASDAQ: ICLR)

467569.jpg

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alexion Pharmaceuticals (NASDAQ: ALXN), Quest Diagnostics Inc (NYSE: DGX) and Icon plc (NASDAQ: ICLR). Alexion Pharmaceuticals (NASDAQ: ALXN) In a report released yesterday,

Oppenheimer Gives a Hold Rating to Alexion Pharmaceuticals

467539.jpg

In a report released yesterday, Hartaj Singh from Oppenheimer reiterated a Hold rating on Alexion Pharmaceuticals (NASDAQ: ALXN). The company’s shares closed yesterday at $130.39. Singh noted: “Alexion (ALXN) reported 4Q16 earnings and provided 2017 guidance that was in line

Analysts Are Bullish on These Healthcare Stocks: ALXN, BCLI

467457.jpg

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alexion Pharmaceuticals (NASDAQ: ALXN) and Brainstorm Cell Therapeutics (NASDAQ: BCLI) with bullish sentiments. Alexion Pharmaceuticals (NASDAQ: ALXN) Cowen & Co. analyst Eric

Alexion Pharmaceuticals Receives a Buy from Piper Jaffray

463878.jpg

Piper Jaffray analyst Joshua Schimmer reiterated a Buy rating on Alexion Pharmaceuticals (NASDAQ: ALXN) on January 4 and set a price target of $176. The company’s shares opened today at $143.61. According to TipRanks.com, Schimmer is ranked 0 out of

Analysts Offer Insights on Healthcare Companies: Alexion Pharmaceuticals (NASDAQ: ALXN), Centene Corp. (NYSE: CNC) and Aldeyra Therapeutics (NASDAQ: ALDX)

463093.jpg

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alexion Pharmaceuticals (NASDAQ: ALXN), Centene Corp. (NYSE: CNC) and Aldeyra Therapeutics (NASDAQ: ALDX) with bullish sentiments. Alexion Pharmaceuticals (NASDAQ: ALXN) Piper Jaffray

Alexion Pharmaceuticals Receives a Hold from Oppenheimer

462635.jpg

Oppenheimer analyst Hartaj Singh initiated coverage with a Hold rating on Alexion Pharmaceuticals (NASDAQ: ALXN) yesterday. The company’s shares closed yesterday at $113.52, close to its 52-week low of $109.12. Singh observed: “We are initiating coverage of Alexion (ALXN) with